Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9137 |
High Similarity |
NPD7266 |
Discontinued |
0.9034 |
High Similarity |
NPD1653 |
Approved |
0.8227 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8199 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.816 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8148 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8148 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8137 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.811 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8058 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8043 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7988 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7939 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7925 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7902 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7867 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7862 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7834 |
Intermediate Similarity |
NPD37 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7799 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7799 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7725 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7698 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7683 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7683 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7673 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7647 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7562 |
Intermediate Similarity |
NPD2801 |
Approved |
0.756 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7545 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7517 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7517 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD228 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7469 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7466 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7427 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7427 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7412 |
Intermediate Similarity |
NPD7240 |
Approved |
0.74 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7365 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7358 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7343 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7315 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7314 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7297 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7292 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.729 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7285 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7266 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7244 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7244 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7239 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7233 |
Intermediate Similarity |
NPD1512 |
Approved |
0.723 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7219 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7209 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7209 |
Intermediate Similarity |
NPD7039 |
Approved |
0.72 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7194 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7188 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7168 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7143 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7133 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7132 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7105 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7097 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7088 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD5585 |
Approved |
0.708 |
Intermediate Similarity |
NPD290 |
Approved |
0.7078 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7063 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7063 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7063 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7041 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7027 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7025 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7024 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7018 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7012 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7007 |
Intermediate Similarity |
NPD968 |
Approved |
0.7007 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.6994 |
Remote Similarity |
NPD3455 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6032 |
Approved |
0.6987 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.698 |
Remote Similarity |
NPD2797 |
Approved |
0.6978 |
Remote Similarity |
NPD3022 |
Approved |
0.6978 |
Remote Similarity |
NPD3021 |
Approved |
0.697 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD291 |
Approved |
0.6962 |
Remote Similarity |
NPD4162 |
Approved |
0.6962 |
Remote Similarity |
NPD4237 |
Approved |
0.6962 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD4678 |
Approved |
0.6951 |
Remote Similarity |
NPD4675 |
Approved |
0.6943 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6939 |
Remote Similarity |
NPD1535 |
Discovery |
0.6933 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6928 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6671 |
Approved |
0.6923 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6918 |
Remote Similarity |
NPD5126 |
Approved |
0.6918 |
Remote Similarity |
NPD5846 |
Approved |
0.6918 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD4626 |
Approved |
0.6918 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD6273 |
Approved |
0.6913 |
Remote Similarity |
NPD8651 |
Approved |
0.6908 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6905 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6903 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6897 |
Remote Similarity |
NPD9545 |
Approved |
0.6897 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6892 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.689 |
Remote Similarity |
NPD3866 |
Clinical (unspecified phase) |
0.689
|
Remote Similarity |
NPD7458 |
Discontinued |